Skip to Main Content

Advertisement

Skip Nav Destination

Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active

Blood Adv (2021) 5 (24): 5536–5545.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement